Search research articles
Contact Us
Filters
Showing results (171-180 of 176) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 176 results.
European Urology Focus
|
July 30, 2017
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study
Andrea Necchi, Gregory R Pond, Marc C Smaldone, et al.
The Lancet. Oncology
|
March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
Nieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
The Lancet. Oncology
|
November 23, 2019
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Daniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 176) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 176 results.
European Urology Focus
|
July 30, 2017
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study
Andrea Necchi, Gregory R Pond, Marc C Smaldone, et al.
The Lancet. Oncology
|
March 5, 2019
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study
Nieves Martínez Chanzá, Wanling Xie, Mehmet Asim Bilen, et al.
Clinical Genitourinary Cancer
|
December 6, 2016
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM<sup>SM</sup>
Joseph I Clark, Michael K K Wong, Howard L Kaufman, et al.
European Urology Focus
|
July 30, 2017
Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis
Andrea Necchi, Luigi Mariani, Salvatore Lo Vullo, et al.
Urologic Oncology
|
August 17, 2025
Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank
Daniel D Shapiro, Edwin Jason Abel, Laurence Albiges, et al.
The Lancet. Oncology
|
November 23, 2019
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
Daniel P Petrylak, Ronald de Wit, Kim N Chi, et al.
Page
of 18